Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the neurological symptoms of long COVID. The study shows that the SARS-CoV-2 ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists have discovered a missing link in autoimmune diseases, offering new hope for treating conditions like COVID-19 and ...

A viral video circulating on social media has reignited questions about the lingering effects of Covid-19 and its vaccines. In the video, a prominent oncologist suggests that spike proteins, either ...

Scientists have uncovered a stealthy tactic used by the SARS-CoV-2 virus: one of its proteins can leap from infected cells to healthy ones, effectively tricking the immune system into attacking the ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

BLOOM (TAMPA) – Chiropractic physician Dr. Cathleen Gerenger joined Gayle Guyardo, host of the global health and wellness show Bloom, to discuss long COVID symptoms and the findings of a recent Yale ...

A protein particle hidden within the SARS-CoV-2 virus could lead to longer-lasting, more protective vaccines for COVID-19. Scientists from La Trobe University and Kumamoto University in Japan have ...

In December 2024, a rumor began spreading online that a team of researchers at Yale University had found the "spike protein" of the SARS-CoV-2 virus, which is responsible for the COVID-19 illness, in ...

Vials of Novavax Covid-19 vaccines arranged at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Novavax's protein-based Covid-19 vaccine received long-sought US emergency-use ...

The US Food and Drug Administration on Friday authorized an updated version of the protein-based Novavax Covid-19 vaccine for use in people 12 and up. Doses could be available by the end of next week.

The Food and Drug Administration authorized Novavax's new protein-based Covid vaccine for emergency use in people ages 12 and up. Novavax's vaccine targets the highly contagious omicron subvariant ...